In this review article, the role of m6A modifications in viral replication and virus–host interactions are examined. In particular, the authors focus on DNA and RNA viruses associated with human diseases including acute SARS-CoV-2, HIV-1, Epstein–Barr virus, and KSHV. The article aims to contribute to the understanding of the mechanisms of virus–host interactions and the design of future therapeutic targets for treatment of tumor associated with viral infections.
Call For Papers
CMBL is currently commissioning a new special collection on Gene regulation tools for treating genetic diseases and cancers based on CRISPR-related technologies. Guest Edited by Yuchen Liu, we welcome the submission of reviews and primary research articles that examine CRISPR-related technologies which have emerged as powerful tools for editing and manipulating genes, and have revolutionized the field of gene therapy. This Collection aims to highlight the latest research and developments in this field, with a focus on the regulatory tools used to treat genetic diseases and cancers.
Submission Deadline: December 31, 2023
-
-
METTL3/YTHDC1-medicated m6A modification of circRNA3634 regulates the proliferation and differentiation of antler chondrocytes by miR-124486-5-MAPK1 axis
-
Metabolite itaconate in host immunoregulation and defense
-
Global research trends in CRISPR-related technologies associated with extracellular vesicles from 2015 to 2022: a bibliometric, dynamic, and visualized study
-
Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer’s disease
-
The usefulness of lactate dehydrogenase measurements in current oncological practice
-
p62 links the autophagy pathway and the ubiqutin–proteasome system upon ubiquitinated protein degradation
-
Cells of human breast milk
-
Progress in research on paclitaxel and tumor immunotherapy
-
Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis
Thematic Series
Gene regulation tools for treating genetic diseases and cancers based on CRISPR-related technologies
Thematic Series
Molecular mechanisms of cell fate decisions during cellular stress
Thematic Series
Collection on Non-coding RNAs
Thematic Series
Celebrating 25 Years of Cellular & Molecular Biology Letters
Thematic Series
Invited papers
Aims and scope
Cellular & Molecular Biology Letters is an international journal dedicated to the dissemination of fundamental knowledge in all areas of cellular and molecular biology, cancer cell biology, and certain aspects of biochemistry, biophysics and biotechnology.
Editor-in-Chief
Aleksander Sikorski, University of Wrocław, Poland
Reviewer Acknowledgements
Please visit the Cellular and Molecular Biology Letters society website and click on "Acknowledgements to Referees" and the year you wish to search to view current and past reviewers
Archival content
Cellular & Molecular Biology Letters was founded in 1996 and transferred to BioMed Central in 2016. Previously, its publishers were Walter De Gruyter in 2015 (content available from De Gruyter's archive), and Springer from 2006–2014 (content available from BMC web page). Articles published between 1996 and 2005 can be found at the CMBL home page, on the Volume List tab. To request free electronic versions of these articles, please contact cmbl@cmbl.org.pl.
Follow
Affiliated with
Annual Journal Metrics
-
2022 Citation Impact
8.3 - 2-year Impact Factor
7.2 - 5-year Impact Factor
1.573 - SNIP (Source Normalized Impact per Paper)
1.643 - SJR (SCImago Journal Rank)2022 Speed
11 days submission to first editorial decision for all manuscripts (Median)
104 days submission to accept (Median)2022 Usage
451,262 downloads
770 Altmetric mentions